In most forms of prion diseases, blood is infectious, but detection by immunochemistry techniques of the only available marker of infection (the misfolded prion protein, PrP TSE ) in blood remains elusive. We developed a novel method for the detection of PrP TSE in blood of prion-infected rodents based on the finding that PrP TSE is associated with plasma exosomes.
Transmissible spongiform encephalopathy (TSE) or prion diseases are fatal neurodegenerative disorders affecting humans and animals caused by unique infectious particles (prions), which are composed mainly of misfolded forms of the cellular prion protein (PrP C ). PrP C is expressed constitutively but converts to the misfolded noxious structure (PrP TSE ) either spontaneously or upon exposure to prions (Weissmann, 2004) . Prions are transmitted efficiently via blood in most animal models of TSE diseases (Brown et al., 2001; Houston et al., 2008) and in humans with variant and possibly sporadic Creutzfeldt-Jakob disease (Llewelyn et al., 2004; Wroe et al., 2006; Puopolo et al., 2011; Douet et al., 2014) . Prion infectivity in blood is associated with both cellular and non-cellular components (Gregori et al., 2006) , with estimated titres in plasma ranging from 1 to 10 IU ml 21 at disease onset (Brown et al., 2001; Douet et al., 2014) . Although plasma has been shown to carry infectivity, the identification of PrP TSE in infected animals and humans has been elusive and limited to the use of highly sensitive (Castilla et al., 2005; Saá et al., 2006; Pan et al., 2007; Orrú et al., 2011) or complex (Edgeworth et al., 2011) methodologies. Because blood components probably interfere with PrP TSE detection (Hartwell et al., 2005; Abdel-Haq, 2015) , we aimed to bypass this difficulty by looking at plasma exosomes. Exosomes are nanovesicles that carry RNA, proteins, lipids, other metabolites (Théry et al., 2009; Fais et al., 2013) , PrP C and, in prion-infected hosts, PrP TSE and infectivity (Fevrier et al., 2004; Alais et al., 2008; Coleman et al., 2012; Saá et al., 2014) .
We first collected blood from intracerebrally 263K scrapieinfected hamsters (n5125) (Kimberlin & Walker, 1977) or from uninfected and healthy animals as controls. Plasma was separated from blood cells by centrifugation at 5000 g for 30 min at room temperature. Single plasma fractions from infected hamsters were pooled to a final volume of 250 ml and used for the measurement of infectivity and purification of exosomes for the detection of PrP TSE by immunochemistry assays (Fig. 1) . A bioassay was performed by intracerebral inoculation of 124 6-week-old female Syrian hamsters with 50 ml thawed plasma, under anaesthesia with a ketamine/xylazine mixture (75 and 10 mg kg 21 , respectively). Animals were housed in accordance with the national guidelines in level 3 animal care facilities (agreement numbers A 92-032-02 for animal care facilities and 92-189 for animal experimentation, CEA, France) and were monitored regularly. Animals with clinical signs or with no disease up to 600-700 days were euthanized, and the brain was removed and tested for the presence of PrP TSE by ELISA as described previously (Barret et al., 2003) . Briefly, PrP TSE was extracted from brains using a Bio-Rad purification kit, digested with proteinase K (PK) and added to anti-PrP SAF53 (Bertin Pharma) mAb-coated ELISA wells. Bound PrP TSE was detected by incubation with the 11C6 (Bertin Pharma) anti-PrP mAb coupled to acetylcholinesterase, and revealed using the Ellman substrate at 414 nm.
Eighteen animals were positive for scrapie (mean time to death¡SEM, 265¡23 days) with a corresponding infectivity titre of 3.1¡0.7 infectious dose (ID) ml 21 (Fig. S1 , available in the online Supplementary Material), in line with previously published results on plasma samples (Brown et al., 2001; Gregori et al., 2006) . Infectivity titre (ID) was calculated by the limiting dilution method according to the Poisson distribution (Gregori et al., 2006) .
From the same pool of plasma, exosomes were isolated from 5 ml aliquots of control and infectious plasma pools using a previously published protocol (Caby et al., 2005) . Briefly, exosomal plasma pellets (EPPs) were prepared by serial centrifugation; the resulting pellets were washed in PBS, filtered through a 0.22 mm filter (Millipore) and ultracentrifuged at 110000 g for 1 h. The EPPs were resuspended in PBS, lysis buffer or in 2.5 M sucrose buffer for further analyses, as indicated in Fig. 1 . Antibodies used for exosomal marker identification were antiflotillin, anti-Tsg101 and anti-mouse CD81 (Santa Cruz Biotechnology). For PrP identification, the primary antibodies used were SAF84 and biotinylated SAF84 (Bertin Pharma), 3F4 (Millipore, Italy) and D18 (gift from R. A. Williamson, Scripps Research Institute, FL, USA). Western blot analyses were performed as described previously (Lee et al., 2000) , and the consistency of these preparations was confirmed by the detection of exosomal markers (Fig. 2a) . Assuming a similar ratio between infectivity and PrP TSE molecules in blood and brain tissue (about 0.1-1 pg PrP TSE per infectious unit; Brown et al., 2001 ), we estimated that 25 ml EPPs, corresponding to 5 ml of the original plasma volume and 15.5 IDs, was suitable for detecting PrP TSE by standard Western blot analyses (Lee et al., 2000) .
In EPPs from control and prion-infected samples, we found that anti-PrP antibodies recognized the Ig light chain (26 kDa) and the IgG (53 kDa) and IgM (65 kDa) heavy chains, as reported previously (Hartwell et al., 2005). These bands were resistant to a concentration of PK (50 mg ml 21 ) that was generally sufficient to remove the bulk of tissue proteins in brain samples (Fig. 2) . The atypical bands were seen irrespective of the anti-PrP primary antibody used (Fig. S2 ) and were not detected in the absence of primary antibodies (Fig. 2a) . They were specific to plasma (Fig. 2a) and were observed in EPPs of other species including humans (data not shown) and WT mice (C57BL/ 10) (Figs. 2a and S2). They were also reproduced in EPPs of PrP knockout 129/Ola mice (gift from Dr Di Bari and Dr Agrimi, Istituto Superiore di Sanità, Rome, Italy) (Figs. 2a and S2), clearly indicating a cross-reaction of the primary antibodies with plasma PK-resistant material, unrelated to PrP epitopes. Finally, when primary anti-PrP antibodies were pre-absorbed with an excess of Syrian hamster 23-231 recombinant PrP (recPrP) (at a ratio of 5:1), Western blot membranes were negative, demonstrating that pre-absorbed primary antibodies are unable to bind PK-resistant Igs (IgRES). These data suggested that the levels of endogenous PrP C in plasma (in the range of pg ml
21
) were not sufficient to replace the non-specific binding of well-represented plasma proteins (in the range of mg ml
).
Stringent PK conditions (100 mg ml 21 ), however, digested high-molecular-mass IgRES bands (Fig. 2a) , allowing the recognition of three bands of the same molecular mass as full-length PrP with a glycoform ratio similar to that observed in hamster brain (Fig. 2a) (Meade-White et al., 2009) . We then further purified the EPPs on a sucrose cushion starting with 15 ml plasma to verify that these bands effectively were full-length PrP. A continuous sucrose gradient for the isolation and purification of exosomes was performed as described previously ( Raposo et al., 1996) , with some modifications. Briefly, purified exosomes were resuspended in 2 ml 2.5 M sucrose, 20 mM HEPES/NaOH (pH 7.2). A linear sucrose gradient (2.0-0.25 M sucrose) was layered on top of the exosome suspension in an UltraClear tube and the sample was centrifuged at 110000 g for 16 h at 48C in a Beckman-Coulter SW41Ti rotor. Gradient fractions (1261 ml) were collected from the top of the tube and washed with PBS. Fraction density was evaluated using an Abbé refractometer (Carl Zeiss).
Silver staining after PAGE and quantification of bands using ImageJ (http://imagej.nih.gov/ij/) showed that, after sucrose-gradient ultracentrifugation, the bulk of the Igs were retained in high-density fractions (1.64-1.70 g ml
), whilst exosomal fractions (1.11-1.13 g ml 21 ) had a significantly lower content of IgRES. On sucrose-gradient-purified EPPs, diglycosylated PrP C bands (37 kDa) were detected at densities of 1.13 g ml 21 and disappeared after PK treatment (Fig. 3) . This fraction was also positive on Western blots using standard exosomal markers (Tsg101, flotillin and CD81) and negative for endoplasmic reticulum and nucleus markers (calnexin and nucleoporin), indicating the purity of the exosomal preparation after sucrose-gradient isolation (Fig. 3) . As controls, the endoplasmic reticulum and nucleus markers gave positive results in the brain homogenate (Fig. 3) .
In infectious EPPs, 37 kDa PrP bands were observed in exosomal fractions at densities of 1.13 g ml 21 (Fig. 3 ). After treatment with PK, PrP-positive bands showed the characteristic shift in molecular mass of PrP TSE (27-30 kDa) with a glycoform ratio similar to that observed in 263K-infected brain homogenate (Fig. 3) . The presence of PrP C on plasma exosomes was further ascertained by electron microscopy. Immunoelectron microscopy was performed on isolated sucrose-gradient fractions of hamster plasma exosomes. A drop of exosome suspension was placed onto a Formvar/carbon-coated grid. After primary antibody (SAF84) incubation, the exosomes were labelled with antirabbit IgG or anti-mouse IgG antibody conjugated to 5 nm diameter gold particles (Sigma-Aldrich). The grids were negatively stained with uranyl acetate solution and examined with a Philips 208 transmission electron microscope (FEI Company). In the 1.13 g ml 21 fraction, there were nanovesicles, which, after immunogold staining, were found to be PrP-positive particles on the surface of nanovesicles (,50 nm) (Fig. S3a, b) . On these samples, nanovesicles of the same size were positive for the standard exosomal marker Rab5b, and no PrP staining was observed in fractions of lower and higher densities (Fig. S3c) . Fig. 3 . Silver staining and Western blots of sucrose-gradient fractions of infected and control EPPs. PAGE silver staining revealed that the bulk of plasma proteins were retained in the high-density fractions of EPPs from both control (cEPP) and infected (iEPP) samples. Western blotting with the SAF84 antibody demonstrated the presence of PrP C in fraction 6 (1.13 g ml
) of cEPPs (n53), which was abolished by the treatment with PK. PK-resistant PrP TSE was detected in fraction 6 of iEPPs. Western blotting of sucrose fractions for exosomal markers (Tsg101, flotillin and CD81) showed that exosomes were found in fractions 5-8. The Finally, to further confirm the presence of prions in plasma exosomes, we measured scrapie infectivity. However, for this experiment we used the mouse-adapted 139A scrapie strain (Dickinson, 1976) , because 139A infectivity, but not 263K infectivity, can be quickly and accurately measured using the scrapie cell end-point assay (SCEPA) (Klöhn et al., 2003) . Susceptible CAD5 cells (a gift from Professor Charles Weissmann, Scripps Research Institute, FL, USA) were seeded into the wells of a 96-well plate and exposed to 12 or more aliquots of the 139A prioncontaining samples for 3 days, grown to confluence and split at a ratio of 1:3 three times and 1:10 twice. When the cells reached confluence, 25 000 cells were transferred to the membranes of ELISPOT plates and PrP TSE -containing cells were identified as spots using the D18 antibody (Fig. S4) . A well was considered positive when the following two criteria were fulfilled: (i) the number of positive spots was higher than the mean plus 5 SDs of unseeded wells (background value); and (ii) prion propagation, revealed by an increased number of positive spots after subsequent passages, was evident. The ID was calculated considering the number of negative wells over the number of positive wells using a Poisson distribution. A titrated brain homogenate was used as a positive control to monitor variations caused by antibodies. Nanovesicles were isolated from 3 ml plasma from 139A-infected mice at the terminal stage. We found one out of six positive wells for the exosomal samples and four out of 48 positive wells for the 1:5 dilution of plasma supernatant. According to the Poisson distribution for rare events, the IDs contained in the processed volume (3 ml) were 1.1 for the exosomal pellet and 4.3 for plasma supernatant. These findings confirmed that in vivo prions are associated with nanovesicles, similar to previous observations in vitro (Fevrier et al., 2004; Fauré et al., 2006; Vella et al., 2007; Alais et al., 2008; Coleman et al., 2012) , and that in plasma, about 20% of total infectivity is associated with exosomes, leaving open the issue of how the remaining infectivity is distributed.
The most important finding of our work was the successful identification of PrP TSE in plasma of scrapie-infected hamsters by standard Western blotting performed on exosomal fractions. This result confirms previous data showing the presence of PrP TSE in blood exosomes by the protein misfolding cyclic amplification (PMCA) method (Saá et al., 2014) , in plasma by PMCA (Castilla et al., 2005) and real-time quaking-induced conversion assays (Orrú et al., 2011) , and in human variant Creutzfeldt-Jakob disease patients by a solid-state binding matrix assay (Edgeworth et al., 2011) , but adds the important novel information that PrP TSE , similarly to infectivity (Brown et al., 2001) , is detectable in blood without using amplification techniques. The detection of PrP TSE by a standard Western blotting technique was only possible after reducing the interference of IgRES by exosomal pellet fractionation on a sucrose gradient. IgRES competes for primary antibody binding with endogenous PrP epitopes, crucially interfering with PrP TSE detection in blood. This result confirmed that blood components interfere with prion diagnosis (Hartwell et al., 2005; Abdel-Haq, 2015) , reducing the sensitivity and specificity of the various tested assays. Moreover, these findings might explain the discrepancy between the excellent performances of tests accomplished on spiked blood and their failure on endogenously infected blood, which is probably related to different interactions with plasma Igs between exogenous and endogenous PrP TSE .
